Mechanisms underlying nonalcoholic steatohepatitis
Publication
, Journal Article
Abdelmalek, MF; Diehl, AM
Published in: Drug Discovery Today Disease Mechanisms
December 1, 2006
Nonalcoholic fatty liver disease (NAFLD), a spectrum of liver damage, encompasses steatosis, steatohepatitis, an intermediate stage of liver disease and cirrhosis. Although NAFLD is the leading cause of chronic liver disease, no effective therapies currently exist. Complex interactions between injury and repair mechanisms likely determine disease progression in NAFLD. The development of successful treatments for NAFLD can be facilitated by understanding disease mechanisms. © 2006 Elsevier Ltd. All rights reserved.
Duke Scholars
Published In
Drug Discovery Today Disease Mechanisms
DOI
ISSN
1740-6765
Publication Date
December 1, 2006
Volume
3
Issue
4
Start / End Page
479 / 488
Related Subject Headings
- Immunology
Citation
APA
Chicago
ICMJE
MLA
NLM
Abdelmalek, M. F., & Diehl, A. M. (2006). Mechanisms underlying nonalcoholic steatohepatitis. Drug Discovery Today Disease Mechanisms, 3(4), 479–488. https://doi.org/10.1016/j.ddmec.2006.11.001
Abdelmalek, M. F., and A. M. Diehl. “Mechanisms underlying nonalcoholic steatohepatitis.” Drug Discovery Today Disease Mechanisms 3, no. 4 (December 1, 2006): 479–88. https://doi.org/10.1016/j.ddmec.2006.11.001.
Abdelmalek MF, Diehl AM. Mechanisms underlying nonalcoholic steatohepatitis. Drug Discovery Today Disease Mechanisms. 2006 Dec 1;3(4):479–88.
Abdelmalek, M. F., and A. M. Diehl. “Mechanisms underlying nonalcoholic steatohepatitis.” Drug Discovery Today Disease Mechanisms, vol. 3, no. 4, Dec. 2006, pp. 479–88. Scopus, doi:10.1016/j.ddmec.2006.11.001.
Abdelmalek MF, Diehl AM. Mechanisms underlying nonalcoholic steatohepatitis. Drug Discovery Today Disease Mechanisms. 2006 Dec 1;3(4):479–488.
Published In
Drug Discovery Today Disease Mechanisms
DOI
ISSN
1740-6765
Publication Date
December 1, 2006
Volume
3
Issue
4
Start / End Page
479 / 488
Related Subject Headings
- Immunology